---
schema_version: "secwatch.filing_event.v1"
accession: "0001534969-24-000151"
form_type: "8-K"
ticker: "SERA"
cik: "0001534969"
company_name: "SERA PROGNOSTICS, INC."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:43:52.541497+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sera Prognostics Q2 2024 net loss narrows to $8.3M; revenue drops to $24k

## Summary
- Q2 2024 revenue was $24,000, down from $123,000 in Q2 2023.
- Net loss improved 21% to $8.3M from $10.5M in Q2 2023.
- Operating expenses decreased 20% to $9.3M; SG&A down 38% to $4.9M, R&D up 19% to $4.4M.
- Published positive AVERT PRETERM TRIAL results; PRIME study database lock expected mid-September; NY State conditional approval for whole-blood collection.

## SEC filing metadata
- accession: 0001534969-24-000151
- form_type: 8-K
- ticker: SERA
- cik: 0001534969
- company_name: SERA PROGNOSTICS, INC.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534969/000153496924000151/0001534969-24-000151-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534969/000153496924000151/sera-20240807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001534969-24-000151
- JSON: https://secwatch.observer/filing/0001534969-24-000151.json
- Plain text: https://secwatch.observer/filing/0001534969-24-000151.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.